Your browser doesn't support javascript.
loading
Upregulated expression of miR-4443 and miR-4488 in drug resistant melanomas promotes migratory and invasive phenotypes through downregulation of intermediate filament nestin.
Castaldo, Vittorio; Minopoli, Michele; Di Modugno, Francesca; Sacconi, Andrea; Liguoro, Domenico; Frigerio, Rachele; Ortolano, Arianna; Di Martile, Marta; Gesualdi, Luisa; Madonna, Gabriele; Capone, Mariaelena; Cirombella, Roberto; Catizone, Angiolina; Del Bufalo, Donatella; Vecchione, Andrea; Carriero, Maria Vincenza; Ascierto, Paolo Antonio; Mancini, Rita; Fattore, Luigi; Ciliberto, Gennaro.
Afiliação
  • Castaldo V; Department of Anatomy, Histology, Forensic- Medicine and Orthopedics, Sapienza University of Rome, 00161, Rome, Italy.
  • Minopoli M; Preclinical Models of Tumor Progression Unit, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', 80131, Naples, Italy.
  • Di Modugno F; Tumor Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, 00144, Rome, Italy.
  • Sacconi A; Clinical Trial Center, Biostatistics and Bioinformatics Unit, IRCCS Regina Elena National Cancer Institute, 00144, Rome, Italy.
  • Liguoro D; Department of Clinical and Molecular Medicine, Sapienza University of Rome, 00161, Rome, Italy.
  • Frigerio R; SAFU Laboratory, Department of Research, Advanced Diagnostics and Technological Innovation, Translational Research Area, IRCCS Regina Elena National Cancer Institute, 00144, Rome, Italy.
  • Ortolano A; SAFU Laboratory, Department of Research, Advanced Diagnostics and Technological Innovation, Translational Research Area, IRCCS Regina Elena National Cancer Institute, 00144, Rome, Italy.
  • Di Martile M; Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, 00144, Rome, Italy.
  • Gesualdi L; Department of Anatomy, Histology, Forensic- Medicine and Orthopedics, Sapienza University of Rome, 00161, Rome, Italy.
  • Madonna G; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', 80131, Naples, Italy.
  • Capone M; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', 80131, Naples, Italy.
  • Cirombella R; Faculty of Medicine and Psychology, Department Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, 00118, Rome, Italy.
  • Catizone A; Department of Anatomy, Histology, Forensic- Medicine and Orthopedics, Sapienza University of Rome, 00161, Rome, Italy.
  • Del Bufalo D; Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, 00144, Rome, Italy.
  • Vecchione A; Faculty of Medicine and Psychology, Department Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, 00118, Rome, Italy.
  • Carriero MV; Preclinical Models of Tumor Progression Unit, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', 80131, Naples, Italy.
  • Ascierto PA; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', 80131, Naples, Italy.
  • Mancini R; Department of Clinical and Molecular Medicine, Sapienza University of Rome, 00161, Rome, Italy.
  • Fattore L; Faculty of Medicine and Psychology, Department Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, 00118, Rome, Italy.
  • Ciliberto G; SAFU Laboratory, Department of Research, Advanced Diagnostics and Technological Innovation, Translational Research Area, IRCCS Regina Elena National Cancer Institute, 00144, Rome, Italy. luigi.fattore@ifo.it.
J Exp Clin Cancer Res ; 42(1): 317, 2023 Nov 27.
Article em En | MEDLINE | ID: mdl-38008717

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: MicroRNAs / Melanoma Limite: Humans Idioma: En Revista: J Exp Clin Cancer Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: MicroRNAs / Melanoma Limite: Humans Idioma: En Revista: J Exp Clin Cancer Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália